Revenue
2010
2011
2012
2013
2015
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | $200,000 | — | $0 | $0 | $0 | $0 | — | — | — | — |
| Research & development | $254,919 | $726,232 | $898,100 | $1.3M | $1.7M | $1.2M | $820,906 | $40,703 | $467,258 | $870,006 | $2.1M | $1.1M | $879,886 | $1.0M | $1.3M | $445,542 | — | — | — | — |
| Operating expenses | $5.1M | $3.6M | $5.1M | $6.3M | $6.7M | $3.3M | $2.5M | $2.1M | $1.8M | $2.1M | $2.8M | $2.4M | $1.4M | $2.1M | $1.9M | $881,684 | — | — | — | — |
| Operating income | −$5.1M | −$3.6M | −$5.1M | −$6.3M | −$6.7M | −$3.3M | −$2.5M | −$2.1M | −$1.8M | −$2.1M | −$2.6M | −$2.4M | −$1.4M | −$2.1M | −$1.9M | −$881,684 | — | — | — | — |
| Net income | −$6.1M | −$3.6M | −$5.1M | −$6.3M | −$6.7M | −$3.3M | −$2.4M | −$2.1M | −$1.8M | −$2.1M | −$2.9M | −$2.8M | −$1.4M | −$3.6M | −$2.1M | −$880,250 | −$1.6M | −$1.3M | −$1.6M | −$562,084 |
| Basic EPSper diluted share | — | -$1.59 | -$2.66 | -$3.99 | -$0.50 | -$0.29 | -$0.22 | -$0.04 | -$0.03 | -$0.04 | -$0.06 | -$0.06 | -$0.03 | -$0.09 | -$0.06 | -$0.03 | — | — | — | — |
| Diluted EPSper diluted share | -$1.26 | -$1.59 | -$2.66 | -$3.99 | -$0.50 | -$0.29 | -$0.22 | -$0.04 | -$0.03 | -$0.04 | -$0.06 | -$0.06 | -$0.03 | -$0.09 | -$0.06 | -$0.03 | — | — | — | — |